Theratechnologies développera la tésamoréline pour le traitement du NASH chez la population générale

NEXT STORY
Immunodiagnostic Market to exhibit a CAGR of 4.7% and Reach USD 22,732.7 Million by 2025, Increasing Awareness for Quality Healthcare Services to Fuel Demand, says Fortune Business Insights
PREV STORY
The Global Monoclonal Antibodies Market is expected to grow by $ 54.55 bn during 2020-2024, progressing at a CAGR of 7% during the forecast period
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

NanoVibronix looks to expand use of its UroShield Due to the potential to impact comorbidities related to COVID-19 Crisis

author_avatar
NASDAQ Market News

IMPACT trial data shows clear benefit in using Roche’s CINtec PLUS Cytology test for women who are at higher risk of developing cervical cancer

author_avatar
NASDAQ Market News

Data to Be Presented at IDWeek™ 2020 Demonstrate the Economic and Clinical Burden of Respiratory and Multi-Virus Infections in Allogeneic Hematopoietic Cell Transplantation Recipients

author_avatar
NASDAQ Market News